Samalin Investment Counsel LLC Cuts Stock Holdings in KKR & Co. Inc. (NYSE:KKR)

Samalin Investment Counsel LLC trimmed its stake in shares of KKR & Co. Inc. (NYSE:KKR) by 7.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,028 shares of the asset manager’s stock after selling 303 shares during the period. Samalin Investment Counsel LLC’s holdings in KKR & Co. Inc. were worth $596,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. AdvisorNet Financial Inc grew its stake in KKR & Co. Inc. by 417.8% during the fourth quarter. AdvisorNet Financial Inc now owns 2,180 shares of the asset manager’s stock valued at $322,000 after acquiring an additional 1,759 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its stake in shares of KKR & Co. Inc. by 8.9% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 57,886 shares of the asset manager’s stock worth $7,559,000 after buying an additional 4,719 shares in the last quarter. Whalen Wealth Management Inc. purchased a new position in shares of KKR & Co. Inc. in the 4th quarter worth $667,000. Caldwell Investment Management Ltd. grew its stake in shares of KKR & Co. Inc. by 2.9% in the 4th quarter. Caldwell Investment Management Ltd. now owns 212,400 shares of the asset manager’s stock worth $31,477,000 after buying an additional 5,900 shares in the last quarter. Finally, Jupiter Asset Management Ltd. grew its stake in shares of KKR & Co. Inc. by 50.9% in the 4th quarter. Jupiter Asset Management Ltd. now owns 114,184 shares of the asset manager’s stock worth $16,889,000 after buying an additional 38,524 shares in the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

KKR & Co. Inc. Trading Down 0.1 %

Shares of KKR opened at $116.54 on Friday. KKR & Co. Inc. has a 1-year low of $91.92 and a 1-year high of $170.40. The company has a 50-day moving average of $139.07 and a 200 day moving average of $141.47. The firm has a market capitalization of $103.52 billion, a price-to-earnings ratio of 35.00, a PEG ratio of 1.00 and a beta of 1.72. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07.

KKR & Co. Inc. Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were issued a dividend of $0.175 per share. The ex-dividend date was Friday, February 14th. This represents a $0.70 dividend on an annualized basis and a yield of 0.60%. KKR & Co. Inc.’s payout ratio is 21.02%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on KKR shares. Morgan Stanley dropped their price objective on shares of KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating for the company in a research note on Thursday, February 6th. Barclays dropped their price objective on shares of KKR & Co. Inc. from $185.00 to $181.00 and set an “overweight” rating for the company in a research note on Wednesday, February 5th. Wells Fargo & Company raised shares of KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and dropped their price objective for the stock from $150.00 to $141.00 in a research note on Thursday. Hsbc Global Res lowered shares of KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a report on Thursday, January 30th. Finally, Oppenheimer raised their target price on shares of KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a report on Thursday, December 12th. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, KKR & Co. Inc. currently has an average rating of “Moderate Buy” and an average target price of $160.79.

Insider Activity at KKR & Co. Inc.

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the firm’s stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the transaction, the insider now owns 19,260,971 shares of the company’s stock, valued at approximately $634,841,604.16. This trade represents a 23.75 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 39.34% of the stock is currently owned by company insiders.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.